Geographic · Product revenues, net
US — Product revenues, net
Insmed US — Product revenues, net increased by 23.9% to $270.07M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 320.2%, from $64.28M to $270.07M. Over 4 years (FY 2021 to FY 2025), US — Product revenues, net shows an upward trend with a 29.8% CAGR.
Analysis
Metric ID:
insm_segment_us_product_revenues_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.75M | $38.51M | $41.99M | $40.78M | $47.19M | $49.54M | $48.48M | $49.07M | $57.67M | $59.2M | $58.26M | $56.35M | $63.79M | $66.87M | $67.79M | $64.28M | $68.68M | $102.04M | $217.96M | $270.07M |
| QoQ Change | — | -7.8% | +9.0% | -2.9% | +15.7% | +5.0% | -2.1% | +1.2% | +17.5% | +2.7% | -1.6% | -3.3% | +13.2% | +4.8% | +1.4% | -5.2% | +6.9% | +48.6% | +113.6% | +23.9% |
| YoY Change | — | — | — | — | +13.0% | +28.6% | +15.5% | +20.3% | +22.2% | +19.5% | +20.2% | +14.8% | +10.6% | +12.9% | +16.4% | +14.1% | +7.7% | +52.6% | +221.5% | +320.2% |
Range$38.51M – $270.07M
CAGR+48.1%
Avg YoY Growth+50.6%
Median YoY Growth+17.9%
Current Streak4 quarters growth
Frequently Asked Questions
- What is Insmed's us — product revenues, net?
- Insmed (INSM) reported us — product revenues, net of $270.07M in Q1 2026.
- How has Insmed's us — product revenues, net changed year-over-year?
- Insmed's us — product revenues, net increased by 320.2% year-over-year, from $64.28M to $270.07M.
- What is the long-term trend for Insmed's us — product revenues, net?
- Over 4 years (2021 to 2025), Insmed's us — product revenues, net has grown at a 29.8% compound annual growth rate (CAGR), from $159.51M to $452.95M.